Risk factors for hospitalization among patients with asthma in Bang Yai Hospital

Authors

  • Dolnapa Pattarathitinan Bang Yai Hospital, Nonthaburi Province

Keywords:

Asthma, Acute asthmatic attack, Asthma management, Hospitalization

Abstract

The purpose of this study was to examine the risk factors for hospitalization among patients with asthma who experienced unpleasant symptoms after receiving inhalants. Data were collected from patients with asthma who visited the emergency department at Bang Yai hospital from October 1st, 2019 to September 30th, 2021 by using retrospective data from the medical records of 294 people. Inpatients were 68 cases. The statistically significant risks of hospitalization were as follows: self-payments increase the risk 8.13 times compared to the universal coverage scheme (gold card), systemic corticosteroids increase the risk 7.27 times, pediatric patients increase the risk 1.95 times and respiratory tract infections reduced the risk by 0.47 times. When analyzing the subgroups, in adults who used self-payment, the risk was 5.08 times higher compared to the gold card scheme. Receiving systemic corticosteroids increased the risk by 4.90 times. The frequency of reliever medication used less than twice a week reduced the risk by 0.22 times, and the risk of partly controlled and uncontrolled asthma decreased by 0.11 and 0.41 times, respectively, compared to the control. In pediatric patients, systemic corticosteroids increased the risk by 8.17 times. Therefore, encouraging patients to access inhaled corticosteroids, treating respiratory infections, and monitoring medication use in a well-controlled group can reduce the patient's chances of hospitalization.

Downloads

Download data is not yet available.

References

Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J. 1998;12(2):315-35.

Global Initiative for asthma. Pocket guide for asthma management and prevention (for adults and children older than 5 years) [Internet]. [cited 2022 April 1]. Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Pocket-Guide-2021-V2-WMS.pdf.

กองโรคจากการประกอบอาชีพและสิ่งแวดล้อม กรมควบคุมโรค กระทรวงสาธารณสุข. คู่มือเฝ้าระวังป้องกัน ควบคุมโรคและภัยที่คุกคามสุขภาพจากฝุ่นละอองขนาดไม่เกิน 2.5 ไมครอน (PM2.5) [อินเตอร์เน็ต]. [สืบค้นเมื่อ 1 เมษายน 2565]. แหล่งข้อมูล: https://ddc.moph.go.th/uploads/publish/1202520211213111057.pdf

Boonpiyathad T, Yimsawad S, Sangasapaviriya A. The cost of asthma treatment in Phramongkutlao Hospital: Population-based study in adults. J Med Assoc Thai. 2016;99(1):51-7.

Chuesakoolvanich K. Cost of hospitalizing asthma patients in a regional hospital in Thailand. Respirology 2007;12(3):433-38.

Mairiang D, Kotruchin P, Phuob K. Triggers and risks factor for admission in patients with asthma exacerbation: A study from an emergency room registration database in a tertiary hospital in Northeastern Thailand. SRIMEDJ. 2020;35(4):410-7.

Scheuerman O, Meyerovitch J, Marcus N, Hoffer V, Batt E, Garty BZ. The september epidemic of asthma in Israel. J Asthma. 2009;46(7):652-55.

Mahdavian M, Power BH, Asghari S, Pike JC. Effects of comorbidities on asthma hospitalization and mortality rates: A systematic review. Can Respir J. 2018;2018: 6460379.

Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109(1):57-62.

Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest. 1997;112(3):591-96.

Gibson PG, Yang IA, Upham JW, et al. Efficacy of azithromycin in severe asthma from the AMAZES randomized trial. ERJ Open Res. 2019;5(4):00056-2019.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev. 2010;(5):CD005535.

Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8(4):161-76.

Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334.

Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992;90(2):250-56.

M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy. 2006;61(1):111-18.

Foresi A, Leone C, Pelucchi A, Mastropasqua B, Chetta A, D'Ippolito R, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol. 1997;100(1):58-64.

Sale R, Silvestri M, Battistini E, Defilippi AC, Sabatini F, Pecora S, et al. Nasal inflammation and bronchial reactivity to methacholine in atopic children with respiratory symptoms. Allergy. 2003;58(11):1171-75.

Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev. 2003;2003(4):CD003570.

Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy. 2001;31(1):61-8.

Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol. 2004;113(3):415-9.

Trivedi M, Denton E. Asthma in Children and Adults-What Are the Differences and What Can They Tell us About Asthma?. Front Pediatr. 2019;7(256): 1-15.

Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24(5):822-33.

Tiotiu A, Ioan I, Wirth N, Romero-Fernandez R, González-Barcala FJ. The impact of tobacco smoking on adult asthma outcomes. Int J Environ Res Public Health. 2021;18(3):992.

Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med. 2010;363(12):1139-45.

Published

2022-09-23

How to Cite

Pattarathitinan, D. (2022). Risk factors for hospitalization among patients with asthma in Bang Yai Hospital. Journal of Medicine and Public Health, Ubon Ratchathani University, 5(3), 181–192. Retrieved from https://he01.tci-thaijo.org/index.php/jmpubu/article/view/256419

Issue

Section

Research Articles